PAA 1.25% 19.8¢ pharmaust limited

Onward and Upward , MPL vs Covid Trial Results Pending ....., page-48

  1. 12,254 Posts.
    lightbulb Created with Sketch. 6245
    The question was "with out limitation of resources" so yes a week..
    same as 2017/2018/2019
    https://stocknessmonster.com/announcements/paa.asx-6A919288/
    PharmAust Completes Scaled Manufacture of Monepantel
    Tablets for Phase I Clinical Trials in Dogs
    • PharmAust settles on final tablet format for dogs.
    • Catalent and PharmAust successfully scale batch method to producing 2000 tablets
    for the Phase I trials in healthy dogs.
    • Scaled manufacture completed.
    7th February 2019 – Perth, Australia: PharmAust Ltd (ASXAA), a clinical-stage oncology
    company, has finalised its monepantel tablet research, development and scaled
    manufacture.

    The Pill presses are fully automated, Stabalisers preservatives , carriers and coatings, once you have run 1 GMP batch the formula and program for the presses are ready to run ,,day and night ,, circa $3m a machine , if PAA has the Oral Treatment for Covid they would be priority customer number 1.

    LEIDEN DATA will be the next catalyst ,, Tick Tock JUNE is here.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.8¢
Change
-0.003(1.25%)
Mkt cap ! $94.89M
Open High Low Value Volume
19.5¢ 19.8¢ 19.5¢ $104.4K 535.4K

Buyers (Bids)

No. Vol. Price($)
2 41474 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 261828 6
View Market Depth
Last trade - 14.46pm 08/10/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.